Holen Sie sich die Stockscreener-App
82.47
0.05%
0.04
Handel nachbörslich:
82.47
Schlusskurs vom Vortag:
$82.43
Offen:
$82.5
24-Stunden-Volumen:
108.31K
Relative Volume:
0.67
Marktkapitalisierung:
$1.86B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
45.07
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
+3.32%
1M Leistung:
-0.12%
6M Leistung:
-17.74%
1J Leistung:
-3.91%
1-Tages-Spanne:
$82.22
$83.46
1-Wochen-Bereich:
$80.24
$83.46
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
82.47 | 1.86B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
493.95 | 177.75B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
182.94 | 53.11B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
90.15 | 45.44B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.50 | 40.35B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
257.76 | 18.95B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Why LeMaitre Vascular Inc. stock attracts strong analyst attentionCapital Efficiency Optimized Stock Alerts Reviewed - metal.it
Backtesting results for LeMaitre Vascular Inc. trading strategiesFree Real Profit Trade Plan Suggestions - Newser
Using data tools to time your LeMaitre Vascular Inc. exitFree Market Surge Signal for Swing Traders - Newser
Comparing LeMaitre Vascular Inc. in custom built stock radarsFree Entry Alert Based on Volume Spikes - Newser
Detecting support and resistance levels for LeMaitre Vascular Inc. Intraday Price Forecast Using Volume Models - Newser
JMP reiterates Market Outperform rating on LeMaitre Vascular stock ahead of earnings - Investing.com Australia
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Wakefield Asset Management LLLP - MarketBeat
How strong is LeMaitre Vascular Inc. company’s balance sheetFree Stock Index Interpretation - jammulinksnews.com
What is the dividend policy of LeMaitre Vascular Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
How Efficient Is LeMaitre Vascular Inc. at Controlling Operating CostsMomentum Buy Alert - metal.it
How LeMaitre Vascular Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser
Victory Capital Management Inc. Has $6.70 Million Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Receives Market Perform Rating from Barrington Research - MarketBeat
Can LeMaitre Vascular Inc. stock recover from recent declineHigh-margin investment plays - jammulinksnews.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Hold" by Analysts - MarketBeat
Analysts Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Target Price at $97.83 - Defense World
What risks could impact LeMaitre Vascular Inc. stock performanceFastest return on investment - jammulinksnews.com
What analysts say about LeMaitre Vascular Inc. stockAccelerated capital growth - PrintWeekIndia
What makes LeMaitre Vascular Inc. stock price move sharplyReal Time Breakout Tracking - Newser
LeMaitre Vascular Inc. Stock Analysis and ForecastRapid wealth accumulation - PrintWeekIndia
New York State Common Retirement Fund Sells 1,296 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Bank of New York Mellon Corp Trims Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Is LeMaitre Vascular Inc. a good long term investmentOutstanding capital returns - jammulinksnews.com
LeMaitre Vascular (LMAT) Maintains "Market Perform" Rating by Ba - GuruFocus
Segall Bryant & Hamill LLC Acquires 17,354 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
What drives LeMaitre Vascular Inc. stock priceFree Market Dynamics Reports - Autocar Professional
Bank of New York Mellon Corp Cuts Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Alps Advisors Inc. Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):